Revolo Biotherapeutics
Phase 2Revolo Biotherapeutics is a revolutionary biotherapeutics company on a mission to revolutionize autoimmune and allergic disease treatment by resetting the immune system for long-term disease remission
Founded
2018
Focus
Biologics
About
Revolo Biotherapeutics is a revolutionary biotherapeutics company on a mission to revolutionize autoimmune and allergic disease treatment by resetting the immune system for long-term disease remission
Funding History
2Total raised: $130M
Series B$100MForbionSep 15, 2023
Series A$30MForbionMar 15, 2021
Company Info
TypePrivate
Founded2018
LocationLondon, United Kingdom
StagePhase 2
Contact
SIMILAR COMPANIES
Abbexa
Pre-clinical · Cambridge
Accentus Medical
Pre-clinical · Oxford
AbOliGo
Pre-clinical · London
Bigespas
Pre-clinical · London
Actimed Therapeutics
Pre-clinical · London
Is this your company?
Claim your profile to update information, add pipeline data, and connect with investors.
Claim profile